Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pivotal phase 3 multicenter, prospective, randomized, placebo-controlled trial of EscharEx

Next Previous
Trial Profile

Pivotal phase 3 multicenter, prospective, randomized, placebo-controlled trial of EscharEx

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 27 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs EscharEx (Primary)
  • Indications Leg ulcer; Varicose ulcer; Wounds
  • Focus Registrational; Therapeutic Use
  • Sponsors MediWound

    • Most Recent Events

    • 21 Dec 2023 According to a MediWound media release, the initiation of the Phase III pivotal study will be in the second half of 2024.
    • 21 Nov 2023 According to a MediWound media release, company was host a conference call for investors on Tuesday, November 21, 2023, beginning at 8:30 a.m
    • 21 Nov 2023 According to a MediWound media release, an updated Phase III protocol will be submitted in the first quarter of 2024 in accordance with recent discussions with the U.S. FDA and EMA.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top